Retinoic acid signaling during priming licenses intestinal CD103+ CD8 TRM cell differentiation.

Authors:
Qiu Z; Khairallah C; Chu TH; Imperato JN; Lei X and 4 more

Journal:
J Exp Med

Publication Year: 2023

DOI:
10.1084/jem.20210923

PMCID:
PMC9960115

PMID:
36809399

Journal Information

Full Title: J Exp Med

Abbreviation: J Exp Med

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Allergy and Immunology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
4/6
66.7% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Evidence found in paper:

"data availability rna sequencing data in fig 4 has been deposited in gene expression omnibus with the accession number gse223983 . data availability rna sequencing data in fig 4 has been deposited in gene expression omnibus with the accession number gse223983"

Code Sharing
Evidence found in paper:

"Disclosures: The authors declare no competing interests exist."

Evidence found in paper:

"We thank Drs. Adrianus van der Velden (Stony Brook University) and Pawan Kumar (Stony Brook University) for constructive discussion on the manuscript. We acknowledge the support of the NIH Tetramer Core Facility for providing MHC I monomers and Dr. Dean Sheppard (University of California, San Francisco, San Francisco, CA, USA) for providing the anti-αvβ8 antibody. Graphical abstract was created with Biorender.com. This study was supported by NIH awards K12GM102778 (Z. Qiu), P01AI056172 (L. Puddington), R01AI076457 (B.S. Sheridan), R01AI172919 (B.S. Sheridan), R21AI137929 (B.S. Sheridan), and funds provided by Stony Brook University (B.S. Sheridan)."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025